Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safety of 5% Minoxidil Foam in the Treatment of Female Androgenetic Alopecia
NCT07080931 is registered in ClinicalTrials.gov with Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safety of 5% Minoxidil Foam in the Treatment of Female Androgenetic Alopecia
- Lead sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 24, 2025
- Completion date
- December 31, 2027
- Enrollment
- 294 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia